Skip to main content
Log in

Serum levels of NCC-ST-439 in Dukes’ C colorectal cancer patients: A preliminary report

  • Short Communication
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

The serum levels of NCC-ST-439, a monoclonal antibody raised against a human gastric cancer xenograft (ST-439), were determined in 28 patients who had undergone a curative resection of Dukes’ C colorectal carcinoma. The preoperative mean levels of NCC-ST-439 were 14.4 U/ml (range 1.0–280.0) and positive (>7.0 U/ml for women under the age of 49, >4.5 U/ml for women over the age of 50, and ment at any age) in 6 patients. Recurrence of the disease after a curative resection was encountered in 7 patients (serum NCC-ST-439 was positive in 5 and negative in 2 patients). The positive serum NCC-ST-439 was associated with a significantly poorer disease-free survival time (P<0.0001). In patients who had undergone a curative resection of Dukes’ C colorectal cancer, the sensitivity of NCC-ST-439 in the sera for recurrent disease was 71.4% and specificity was 95.2%. The results of a preliminary study suggested NCC-ST-439 to be a novel marker for predicting recurrence after a curative resection of Dukes’ C colorectal carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Hirohashi S, Watanabe M, Shimosato Y, Sekine T (1984) Monoclonal antibody reactive with the sialyl-sugar residue of a high molecular weight glycoprotein in sera of cancer patients. Gann (Jpn J Cancer Res) 75:485–488

    CAS  PubMed  Google Scholar 

  2. Watanabe M, Hirohashi S, Shimosato Y, Ino Y, Yamada T, Teshima S, Sekine T, Abe O (1985) Carbohydrate antigen defined by a monoclonal antibody raised against a gastric cancer xenograft. Gann (Jpn J Cancer Res) 76:43–52

    CAS  PubMed  Google Scholar 

  3. Ohkura H, Hattori N, Miyazaki I, Sawabu N, Tobe T, Kawai K, Abe O, Ishii M, Kawai T, Kamano T, Kurihara M, Mizumoto R (1987) Clinical study of the NCC-ST-439 EIA kit using serum from patients with various types of cancer and benign disease (2) (in Japanese). Gann to Kagakuryoho (Jpn J Cancer Chemother) 14(I):1907–1912

    CAS  Google Scholar 

  4. Hansen HJ, Lance KP, Kruppey J (1971) Demonstration of an ion sensitive antigeic site on carcinoembryonic antigen using zirconyl phosphate gel (abstract). Clin Res 19:143–143

    Google Scholar 

  5. Roberts PJ (1988) Tumour markers in colorectal cancer. Scand J Gastroenterol 23:50–58

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matsumoto, K., Kinoshita, T., Ishida, T. et al. Serum levels of NCC-ST-439 in Dukes’ C colorectal cancer patients: A preliminary report. Surg Today 29, 91–92 (1999). https://doi.org/10.1007/BF02482979

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02482979

Key Words

Navigation